You are here

Pfizer boosts China presence with US$350m biotech plant

Facility to be completed in 2018, will make biologics and cheaper versions


PFIZER Inc will invest US$350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the world's second largest pharmaceutical market despite slowing economic growth in the country and rising pressure on prices for medicines.

The new